세계의 DNA 인코딩 라이브러리 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 제품 및 서비스별, 치료 영역별, 용도별, 최종 용도별, 지역별, 경쟁별(2020-2030년)
DNA-encoded Library Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Service, By Therapeutic Area, By Application, By End Use, By Region and Competition, 2020-2030F
상품코드:1738270
리서치사:TechSci Research
발행일:2025년 05월
페이지 정보:영문 186 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 DNA 인코딩 라이브러리(DEL) 시장은 2024년에 7억 6,208만 달러로 평가되었고, 2030년까지는 16억 3,226만 달러에 이를것으로 예측되며, CAGR 13.51%로 성장할 전망입니다.
DEL 기술은 수십억 개의 화합물을 동시에 스크리닝할 수 있게 함으로써 초기 단계의 신약 발견을 혁신하고 있으며, 이를 통해 효율성을 높이고 적중 물질을 빠르게 식별할 수 있습니다. 제약 및 생명공학 회사들이 생리활성 분자 발견을 위한 확장 가능하고 비용 효율적인 플랫폼을 찾으면서, DEL은 높은 처리량과 화학적 다양성으로 인해 주목을 받고 있습니다. R&D 투자 증가, 개인 맞춤형 의약품에 대한 관심 증가, 더 빠른 치료제 개발에 대한 요구가 계속해서 도입을 촉진하고 있습니다. 인공 지능과 머신 러닝을 DEL 워크플로우에 통합하면 화합물 분석, 리드 선택, 예측 모델링이 더욱 향상됩니다. 인코딩 화학 및 화합물 스캐폴드의 기술 혁신과 하이브리드 스크리닝 전략의 등장으로 DEL 시장은 지속적으로 견고한 성장을 이어갈 것입니다.
시장 개요
예측 기간
2026-2030년
시장 규모(2024년)
7억 6,208만 달러
시장 규모(2030년)
16억 3,226만 달러
CAGR(2025-2030년)
13.51%
급성장 부문
히트 검증/최적화
최대 시장
북미
주요 시장 성장 촉진요인
효율적인 신약 개발 방법에 대한 수요 증가
주요 시장 과제
라이브러리 설계 및 합성의 복잡성
주요 시장 동향
고처리량 스크리닝 기술의 채택 증가
목차
제1장 제품 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 DNA 인코딩 라이브러리 시장 전망
시장 규모와 예측
금액별
시장 점유율 및 예측
제품 및 서비스별(키트 및 시약, 인코딩 라이브러리, 설계 및 합성 서비스, 스크리닝 서비스, 기타)
치료 영역별(종양학, 감염증, 심혈관 질환, 신경 질환, 자가면역 질환, 대사성 질환, 기타)
용도별(히트 생성/식별, 히트 투 리드, 히트 검증/최적화, 기타)
최종 용도별(학술 및 연구기관, 제약 및 생명공학 기업, 위탁 연구 기관, 기타)
기업별(2024년)
지역별
시장 맵
제6장 북미의 DNA 인코딩 라이브러리 시장 전망
시장 규모와 예측
시장 점유율 및 예측
북미 : 국가별 분석
미국
멕시코
캐나다
제7장 유럽의 DNA 인코딩 라이브러리 시장 전망
시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 DNA 인코딩 라이브러리 시장 전망
시장 규모와 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
중국
인도
한국
일본
호주
제9장 남미의 DNA 인코딩 라이브러리 시장 전망
시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 DNA 인코딩 라이브러리 시장 전망
시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
합병과 인수
제품 출시
최근 동향
제13장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협
제14장 경쟁 구도
Merck KGaA
GenScript Biotech Corporation
Pharmaron Beijing Co., Ltd.
WuXi AppTec Co., Ltd.
Aurigene Pharmaceutical Services Limited
BOC Sciences
LGC Bioresearch Technologies
SPT Labtech Ltd.
Charles River Laboratories International, Inc.
Life Chemicals Inc.
제15장 전략적 제안
제16장 기업 소개와 면책사항
HBR
영문 목차
영문목차
The Global DNA-encoded Library (DEL) Market was valued at USD 762.08 Million in 2024 and is projected to reach USD 1632.26 Million by 2030, growing at a CAGR of 13.51%. DEL technology is revolutionizing early-stage drug discovery by enabling simultaneous screening of billions of compounds, which enhances efficiency and accelerates hit identification. As pharmaceutical and biotech companies seek scalable, cost-effective platforms for bioactive molecule discovery, DELs are gaining traction due to their high-throughput capabilities and chemical diversity. Increased R&D investment, growing interest in personalized medicine, and the demand for faster therapeutic development continue to drive adoption. Integration of artificial intelligence and machine learning into DEL workflows further enhances compound analysis, lead selection, and predictive modeling. With technological innovations in encoding chemistries and compound scaffolds, and the emergence of hybrid screening strategies, the DEL market is poised for continued robust growth.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 762.08 Million
Market Size 2030
USD 1632.26 Million
CAGR 2025-2030
13.51%
Fastest Growing Segment
Hit Validation/Optimization
Largest Market
North America
Key Market Drivers
Rising Demand for Efficient Drug Discovery Methods
The surge in demand for efficient drug discovery methods is a major factor driving the growth of the DEL market. Traditional drug discovery involves extensive time and financial investment, often with low success rates. DELs address this issue by enabling the rapid screening of billions of small molecules tagged with unique DNA barcodes, allowing researchers to identify promising interactions with target proteins more effectively. This method significantly reduces the time and cost associated with early-stage drug development. As pharmaceutical companies aim to speed up the development of targeted therapies for complex conditions such as cancer and neurological disorders, the scalability and precision of DEL technology offer a compelling advantage. The ability to explore vast chemical spaces and develop tailored treatments aligns with the industry's shift toward precision medicine, reinforcing DEL's role as a vital tool in modern drug discovery.
Key Market Challenges
Complexity of Library Design and Synthesis
The intricate process of designing and synthesizing DNA-encoded libraries presents a key challenge to market growth. Creating diverse libraries requires specialized expertise in conjugating small molecules with DNA tags, with multiple synthesis steps that must be precisely executed. Maintaining the fidelity and reproducibility of libraries across large datasets is a technical hurdle, as errors in encoding can lead to inaccurate screening outcomes. Additionally, balancing chemical diversity with biological compatibility limits the scope of compound design. Some complex molecules or desired modifications may be difficult to synthesize or require extensive refinement, increasing time and costs. These complexities affect consistency and scalability, especially during transition from discovery to lead optimization.
Key Market Trends
Increasing Adoption of High-Throughput Screening Technologies
High-throughput screening (HTS) technologies are becoming increasingly integrated with DEL platforms, enabling rapid evaluation of millions to billions of compounds. This combination boosts drug discovery efficiency by reducing time and cost while increasing hit identification accuracy. Advances in automation, robotics, and data analytics are optimizing HTS workflows, making them more adaptable to DEL applications. Artificial intelligence and machine learning algorithms are further enhancing analysis by improving target interaction predictions and prioritizing hits. These capabilities are essential in the discovery of novel therapeutics for oncology, infectious diseases, and neurological disorders, fueling broader market adoption.
Key Market Players
Merck KGaA
GenScript Biotech Corporation
Pharmaron Beijing Co., Ltd.
WuXi AppTec Co., Ltd.
Aurigene Pharmaceutical Services Limited
BOC Sciences
LGC Bioresearch Technologies
SPT Labtech Ltd.
Charles River Laboratories International, Inc.
Life Chemicals Inc.
Report Scope
In this report, the Global DNA-encoded Library Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
DNA-encoded Library Market, By Product & Service:
Kits & Reagents
Encoded Libraries
Design & Synthesis Services
Screening Services
Others
DNA-encoded Library Market, By Therapeutic Area:
Oncology
Infectious Diseases
Cardiovascular Diseases
Neurological Diseases
Autoimmune Diseases
Metabolic Diseases
Others
DNA-encoded Library Market, By Application:
Hit Generation / Identification
Hit to Lead
Hit Validation / Optimization
Others
DNA-encoded Library Market, By End Use:
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Others
DNA-encoded Library Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global DNA-encoded Library Market.
Available Customizations
Global DNA-encoded Library Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global DNA-encoded Library Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product & Service (Kits & Reagents, Encoded Libraries, Design & Synthesis Services, Screening Services, Others)
5.2.2. By Therapeutic Area (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Diseases, Autoimmune Diseases, Metabolic Diseases, Others)
5.2.3. By Application (Hit Generation / Identification, Hit to Lead, Hit Validation / Optimization, Others)
5.2.4. By End Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Others)
5.2.5. By Company (2024)
5.2.6. By Region
5.3. Market Map
6. North America DNA-encoded Library Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product & Service
6.2.2. By Therapeutic Area
6.2.3. By Application
6.2.4. By End Use
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States DNA-encoded Library Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product & Service
6.3.1.2.2. By Therapeutic Area
6.3.1.2.3. By Application
6.3.1.2.4. By End Use
6.3.2. Mexico DNA-encoded Library Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product & Service
6.3.2.2.2. By Therapeutic Area
6.3.2.2.3. By Application
6.3.2.2.4. By End Use
6.3.3. Canada DNA-encoded Library Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product & Service
6.3.3.2.2. By Therapeutic Area
6.3.3.2.3. By Application
6.3.3.2.4. By End Use
7. Europe DNA-encoded Library Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product & Service
7.2.2. By Therapeutic Area
7.2.3. By Application
7.2.4. By End Use
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France DNA-encoded Library Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product & Service
7.3.1.2.2. By Therapeutic Area
7.3.1.2.3. By Application
7.3.1.2.4. By End Use
7.3.2. Germany DNA-encoded Library Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product & Service
7.3.2.2.2. By Therapeutic Area
7.3.2.2.3. By Application
7.3.2.2.4. By End Use
7.3.3. United Kingdom DNA-encoded Library Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product & Service
7.3.3.2.2. By Therapeutic Area
7.3.3.2.3. By Application
7.3.3.2.4. By End Use
7.3.4. Italy DNA-encoded Library Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product & Service
7.3.4.2.2. By Therapeutic Area
7.3.4.2.3. By Application
7.3.4.2.4. By End Use
7.3.5. Spain DNA-encoded Library Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product & Service
7.3.5.2.2. By Therapeutic Area
7.3.5.2.3. By Application
7.3.5.2.4. By End Use
8. Asia-Pacific DNA-encoded Library Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product & Service
8.2.2. By Therapeutic Area
8.2.3. By Application
8.2.4. By End Use
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China DNA-encoded Library Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product & Service
8.3.1.2.2. By Therapeutic Area
8.3.1.2.3. By Application
8.3.1.2.4. By End Use
8.3.2. India DNA-encoded Library Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product & Service
8.3.2.2.2. By Therapeutic Area
8.3.2.2.3. By Application
8.3.2.2.4. By End Use
8.3.3. South Korea DNA-encoded Library Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product & Service
8.3.3.2.2. By Therapeutic Area
8.3.3.2.3. By Application
8.3.3.2.4. By End Use
8.3.4. Japan DNA-encoded Library Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product & Service
8.3.4.2.2. By Therapeutic Area
8.3.4.2.3. By Application
8.3.4.2.4. By End Use
8.3.5. Australia DNA-encoded Library Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product & Service
8.3.5.2.2. By Therapeutic Area
8.3.5.2.3. By Application
8.3.5.2.4. By End Use
9. South America DNA-encoded Library Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product & Service
9.2.2. By Therapeutic Area
9.2.3. By Application
9.2.4. By End Use
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil DNA-encoded Library Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product & Service
9.3.1.2.2. By Therapeutic Area
9.3.1.2.3. By Application
9.3.1.2.4. By End Use
9.3.2. Argentina DNA-encoded Library Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product & Service
9.3.2.2.2. By Therapeutic Area
9.3.2.2.3. By Application
9.3.2.2.4. By End Use
9.3.3. Colombia DNA-encoded Library Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product & Service
9.3.3.2.2. By Therapeutic Area
9.3.3.2.3. By Application
9.3.3.2.4. By End Use
10. Middle East and Africa DNA-encoded Library Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product & Service
10.2.2. By Therapeutic Area
10.2.3. By Application
10.2.4. By End Use
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa DNA-encoded Library Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product & Service
10.3.1.2.2. By Therapeutic Area
10.3.1.2.3. By Application
10.3.1.2.4. By End Use
10.3.2. Saudi Arabia DNA-encoded Library Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product & Service
10.3.2.2.2. By Therapeutic Area
10.3.2.2.3. By Application
10.3.2.2.4. By End Use
10.3.3. UAE DNA-encoded Library Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product & Service
10.3.3.2.2. By Therapeutic Area
10.3.3.2.3. By Application
10.3.3.2.4. By End Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Porters Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. Merck KGaA
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. GenScript Biotech Corporation
14.3. Pharmaron Beijing Co., Ltd.
14.4. WuXi AppTec Co., Ltd.
14.5. Aurigene Pharmaceutical Services Limited
14.6. BOC Sciences
14.7. LGC Bioresearch Technologies
14.8. SPT Labtech Ltd.
14.9. Charles River Laboratories International, Inc.
